{"id":"W3004681236","doi":"10.1093/rheumatology/kez684","title":"Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1)","year":2020,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Celgene; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Ixekizumab; Placebo; Internal medicine; Adalimumab; Psoriatic arthritis; Gastroenterology; Psoriasis Area and Severity Index; Psoriasis; Randomized controlled trial; Arthritis; Rheumatoid arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007660718,0.0003378073,0.001224789,0.00004500628,0.00009710406,0.00001521293,0.00009559772,0.0001815796,0.0001243813],"category_scores_gemma":[0.000334508,0.0002340041,0.0002971897,0.0002090517,0.000166492,0.00007699668,0.00005467589,0.0001540568,0.00006730168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001000591,"about_ca_system_score_gemma":0.0001160929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004201032,"about_ca_topic_score_gemma":0.0001206473,"domain_scores_codex":[0.9975593,0.0001274568,0.0009078682,0.0006942691,0.0003607686,0.0003503311],"domain_scores_gemma":[0.9984525,0.0002738737,0.0004015064,0.0004214018,0.0001595989,0.0002910452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6082048,0.01095189,0.01829472,0.00001353452,0.002518537,0.0004850432,0.002279009,9.653602e-7,0.00001863254,0.00002918801,0.0007868651,0.3564168],"study_design_scores_gemma":[0.8327745,0.0822533,0.06993228,0.0002200228,0.0007593991,0.00000291635,0.0005282356,0.00001853599,0.0004293213,0.00004218748,0.01275083,0.0002884798],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927104,0.0007353918,0.00001078161,0.0007656369,0.0003499957,0.002063389,0.002582051,0.00007504522,0.0007072905],"genre_scores_gemma":[0.9952379,0.001255886,0.0007985566,0.0002845459,0.0007239946,0.0001208063,0.001493038,0.00003312199,0.00005217351],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3561283,"threshold_uncertainty_score":0.9542412,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05389112942474778,"score_gpt":0.3352843259913323,"score_spread":0.2813931965665846,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}